https://www.avient.com/knowledge-base/article/injection-molding-mold-design
A-2
D-2
1, 2 and 4
https://www.avient.com/sites/default/files/2020-03/Global_High_Yield_%26_Leverage_Conference %281%29.pdf
Investor Day G L O B A L H I G H Y I E L D & L E V E R A G E D F I N A N C E C O N F E R E N C E F E B R U A R Y 2 0 2 0 FORWARD LOOKING STATEMENTS PolyOne Corporation 2 In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Binder • PET, Polyester, Kevlar yarns coated with Swellcoat (absorbs and blocks water) 2 3 4 5 7 6 8 9.
Service:�The Timeless differentiator Talent development IQ DESIGN LSS CUSTOMER FIRST Innovating with PolyOne COLOR, ADDITIVES & INKS Color, Additives & Inks Specialty Engineered Materials Specialty Engineered Materials DISTRIBUTION Overview of RAW MATERIAL PURCHASES Target end markets & �application examples Slide Number 52 Slide Number 53 Slide Number 54 Slide Number 55 Slide Number 56 Slide Number 57 Slide Number 58 Slide Number 59 Slide Number 60 Slide Number 61 Slide Number 62 Slide Number 63 Slide Number 64 Slide Number 65
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Gabelli%2520%2526%2520Co%2520Specialty%2520Chemicals%2520Conference.pdf
PolyOne Investor Presentation PolyOne Investor Presentation March 2018 POLYONE CORPORATION 2 In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
PolyOne �Investor Presentation Slide Number 2 Slide Number 3 Slide Number 4 Slide Number 5 Slide Number 6 Slide Number 7 Slide Number 8 Slide Number 9 Slide Number 10 Slide Number 11 Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 Slide Number 23 Slide Number 24 Slide Number 25 Slide Number 26 Slide Number 27 Slide Number 28 Slide Number 29 Slide Number 30 Slide Number 31 Slide Number 32 Investor Presentation - March 2018 r4.pdf Investor Presentation - March 2018
https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-processing-guide.pdf
Place vents at the end of fill and anywhere potential knit/weld lines will occur. 2.
Enlarge or widen vents and increase number of vents 2.
Clean, widen and increase number of vents 2.
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2019-results
Great Place
Attachment 2
2)
https://www.avient.com/sites/default/files/2021-05/avient-colorants-singapore-acra-business-profile-may-17-2021.pdf
: 27/05/2019 Company Type : PRIVATE COMPANY LIMITED BY SHARES Status : Live Company Status Date : 27/05/2019 Principal Activities Activities (I) WHOLESALE OF CHEMICALS AND CHEMICAL PRODUCTS N.E.C. (46649): : Description MANUFACTURE OF ADDITIVES N.E.C. (20249): Activities (II) : Description Capital CurrencyIssued Share Capital Share TypeNumber of Shares * (AMOUNT) 3000000 SINGAPORE, DOLLARS ORDINARY3000000 * Number of Shares includes number of Treasury Shares CurrencyPaid-Up Capital Share TypeNumber of Shares (AMOUNT) 3000000 SINGAPORE, DOLLARS ORDINARY Number Of Shares Currency COMPANY HAS THE FOLLOWING ORDINARY SHARES HELD AS TREASURY SHARES Page 1 of 4 Authentication No. : T21361090D Date: 17/05/2021 ACCOUNTING AND CORPORATE REGULATORY AUTHORITY WHILST EVERY ENDEAVOR IS MADE TO ENSURE THAT INFORMATION PROVIDED IS UPDATED AND CORRECT.
Date Registered Source of Address ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Address Date of Appointment SOH SOCK LAN S1189628F SINGAPORE CITIZEN 01/06/2020ACRA Director47 JURONG EAST AVENUE 1 #03-01 PARC OASIS SINGAPORE (609780) LIM JOO ANN S8679985E MALAYSIAN 01/06/2020ACRA Director311 JURONG EAST STREET 32 #02-331 JURONG EAST 32 SINGAPORE (600311) IAN NG FOOK YUN S2565916C SINGAPORE CITIZEN 27/05/2019ACRA Secretary151 CAVENAGH ROAD #09-161 CAVENAGH COURT SINGAPORE (229628) ANNA MARDIANA ALISJAHBANA S2205619J SINGAPORE CITIZEN 27/05/2019ACRA Page 2 of 4 Authentication No. : T21361090D Date: 17/05/2021 ACCOUNTING AND CORPORATE REGULATORY AUTHORITY WHILST EVERY ENDEAVOR IS MADE TO ENSURE THAT INFORMATION PROVIDED IS UPDATED AND CORRECT.
LTD. (201916958N) (ACRA) Source of Address ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Address Date of Appointment Secretary46 EASTWOOD ROAD #04-06 LAGUNA 88 SINGAPORE (486356) Shareholder(s) Name Address ID Nationality/Citizenship Place of incorporation/ Origin/Registration Source of Address Address Changed AVIENT SWITZERLAND GMBH T16UF0762F SWITZERLAND ACRA1 ROTHAUSSTRASSE 61 4132 MUTTENZ, SWITZERLAND Ordinary(Number) Currency 3000000 SINGAPORE, DOLLARS Abbreviation UL - Local Entity not registered with ACRA UF - Foreign Entity not registered with ACRA AR - Annual Return AGM - Annual General Meeting FS - Financial Statements OSCARS - One Stop Change of Address Reporting Service by Immigration & Checkpoint Authority.
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
Avient corporation first quarter 2023 results AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) F E B R UA RY 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- FE BRUARY 14 , 2024 W E BCAS T P RE S E N TAT I O N DR.
Free Cash Flow Calculation December 31, 2023 Cash provided by operating activities $ 201.6 Taxes paid on gain on sale of business 104.1 Adjusted cash provided by operating activities $ 305.7 Capital expenditures $ (119.4) Free cash flow $ 186.3 2 Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales: Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0 Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4 Corporate (0.2) (1.2) (2.8) (2.5) Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Operating income: Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0 Specialty Engineered Materials 29.4 35.2 142.5 140.1 Corporate (48.1) (79.1) (205.6) (197.8) Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3 Other expense, net: $ 4.3 $ (28.4) $ 5.8 $ (59.7) Depreciation & amortization: Color, Additives and Inks $ 22.2 $ 25.2 $ 98.3 $ 101.3 Specialty Engineered Materials 19.8 20.3 81.5 48.7 Corporate 2.2 3.1 9.0 12.5 Depreciation & amortization $ 44.2 $ 48.6 $ 188.8 $ 162.5 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 84.0 $ 69.5 $ 358.2 $ 402.3 Specialty Engineered Materials 49.2 55.5 224.0 188.8 Corporate (45.9) (76.0) (196.6) (185.3) Other expense, net $ 4.3 $ (28.4) $ 5.8 $ (59.7) EBITDA $ 91.6 $ 20.6 $ 391.4 $ 346.1 Special items in EBITDA 22.3 86.8 110.4 162.5 EBITDA - excluding special items $ 113.9 $ 107.4 $ 501.8 $ 508.6 APM pro forma adjustments - 8 months 2022* — — — 83.1 Pro forma EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7 * Pro forma adjustment for January - August 2022 APM results (period before Avient ownership). 3 AVNT February IR Presentation_w_Non-GAAP Recs.pdf AVNT February IR Presentation.pdf Avient corporation�investor presentation DISCLAIMER Slide Number 3 Creating a world-class�sustainable organization Top-tier sustainability performance�and recognition Slide Number 6 Slide Number 7 Portfolio transformation Slide Number 9 END MARKET observations�(% of company sales) Regional observations�(% of company sales) Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 2023 segment, end market and Geography Color, Additives & Inks Specialty Engineered Materials Slide Number 26 AVNT Q4 2023 Earnings Presentation.pdf AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf IR Deck - AVNT-2023.12.31 (2.12.24 9PM Milestone February 12 0905 pm).pdf Attachment 3.26.24 - Public Lender Presentation Non-GAAP Attachments (005).pdf
https://www.avient.com/sites/default/files/2023-04/Avient_supplierFAQ.pdf
Purchase Orders In what format will I receive now my purchase orders from Avient?
Select and open the applicable Coupa Notification email 2.
There, input the invoice number into the Invoice # field 4.
https://www.avient.com/sites/default/files/2023-11/AVNT November IR Presentation.pdf
AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) N OV E M B E R 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,120 2016 2018 2020 2023E $51 $84 $212 $650 2016 2018 2020 2023E $108 $113 $231 $230 2016 2018 2020 2023E $265 $358 $726 $730 2016 2018 2020 2023E 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023E EBITDA Margins $0.14 $1.93 $2.30 2006 2014 2023E Adjusted EPS TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 3 5 5 87th 94th percentile Innovation is the lifeblood of a specialty company.
Three Months Ended September 30, 2023 Three Months Ended September 30, 2022 Reconciliation to Condensed Consolidated Statements of Income: $ EPS $ EPS Net income (loss) from continuing operations attributable to Avient shareholders $ 5.1 $ 0.06 $ (27.4) $ (0.30) Special items, after tax 32.0 0.35 68.3 0.75 Amortization expense, after-tax 15.2 0.16 $ 13.4 $ 0.14 Adjusted net income / EPS $ 52.3 $ 0.57 $ 54.3 $ 0.59 Three Months Ended September 30, Reconciliation to EBITDA and Adjusted EBITDA: 2023 2022 Sales - GAAP $ 753.7 $ 823.3 Pro Forma APM adjustments — 60.7 Pro forma adjusted sales $ 753.7 $ 884.0 Net income from continuing operations – GAAP $ 5.1 $ (27.8) Income tax (benefit) expense (0.1) (1.2) Interest expense, net 30.3 37.3 Depreciation and amortization 46.4 39.8 EBITDA from continuing operations $ 81.7 $ 48.1 Special items, before tax 43.2 82.0 Interest expense included in special items (2.2) (10.0) Depreciation and amortization included in special items — (0.8) Adjusted EBITDA $ 122.7 $ 119.3 Pro forma APM adjustments — 17.2 Pro forma adjusted EBITDA $ 122.7 $ 136.5 Pro forma adjusted EBITDA as a % of sales 16.3 % 15.4 % 1 Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA: 2006 2018 Sales $ 2,622.4 $ 3,533.4 Net income from continuing operations – GAAP $ 133.5 $ 160.8 Income tax expense 29.7 36.4 Interest expense, net 63.1 62.8 Depreciation and amortization 57.1 91.5 EBITDA from continuing operations $ 283.4 $ 351.5 Special items, before tax (34.0) 59.5 Depreciation and amortization included in special items — (3.0) JV - equity income (107.0) — Adjusted EBITDA $ 142.4 $ 408.0 Adjusted EBITDA as a % of sales 5.4 % 11.5 % Reconciliation to EBITDA and Adjusted EBITDA: Three Months Ended December 31, 2022 Net loss from continuing operations – GAAP $ (16.6) Income tax benefit (60.8) Interest expense, net 49.4 Depreciation and amortization 48.6 EBITDA from continuing operations $ 20.6 Special items, before tax 104.3 Interest expense included in special items (16.0) Depreciation and amortization included in special items (1.5) Adjusted EBITDA $ 107.4 Reconciliation of Pro Forma Adjusted Earnings per Share: Three Months Ended December 31, 2022 Net loss from continuing operations attributable to Avient shareholders $ (17.0) Special items, after tax 38.3 Amortization expense, after-tax 14.6 Adjusted net income from continuing operations excluding special items 35.9 Pro forma adjustments* 2.5 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 38.4 Weighted average diluted shares 91.7 Pro forma adjusted EPS - excluding special items pro forma for APM acquisition $ 0.42 * Pro forma adjustment to reflect APM results for the period before Avient ownership including the impacts of debt financing and paydown of debt with net proceeds from the Distribution sale. 2 AVNT November IR Presentation (11.3) 3PM Avient corporation�investor presentation DISCLAIMER Slide Number 3 Creating a world-class�sustainable organization Top-tier sustainability performance�and recognition What we do: We are a formulator Slide Number 7 Avient protective materials �First Year Slide Number 9 Slide Number 10 Slide Number 11 Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 Slide Number 23 Slide Number 24 Slide Number 25 Avient is asset light Free cash flow conversion Multiple expansion Slide Number 29 Slide Number 30 Slide Number 31 2022 pro forma segment, end market and Geography Color, Additives & Inks Specialty Engineered Materials Slide Number 35 IR Deck - AVNT-2023.09.30 Non GAAP Recs Attachment
https://www.avient.com/investor-center/news/avient-hold-third-quarter-2023-conference-call
Thursday, November 2, 2023
Thursday, November 2, 2023
Great Place